These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 7732839)

  • 1. Formation of F2-isoprostanes during the oxidation of human low density lipoprotein by peroxynitrite.
    Moore KP; Darley-Usmar V; Morrow J; Roberts LJ
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():225-7. PubMed ID: 7732839
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.
    Moore KP; Darley-Usmar V; Morrow J; Roberts LJ
    Circ Res; 1995 Aug; 77(2):335-41. PubMed ID: 7614720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidation and antioxidation of human low-density lipoprotein and plasma exposed to 3-morpholinosydnonimine and reagent peroxynitrite.
    Thomas SR; Davies MJ; Stocker R
    Chem Res Toxicol; 1998 May; 11(5):484-94. PubMed ID: 9585479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by glucose of low density lipoprotein-oxidation by peroxynitrite.
    Schneider D; Elstner EF
    Z Naturforsch C J Biosci; 1999 Nov; 54(11):956-62. PubMed ID: 10627995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenolic acids protect low density lipoproteins from peroxynitrite-mediated modification in vitro.
    Morton LW; Croft KD; Puddey IB; Byrne L
    Redox Rep; 2000; 5(2-3):124-5. PubMed ID: 10939290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGF2-isoprostanes formed during copper-induced oxidation of low-density lipoproteins are the prostaglandins that cross-react with PGE2 antibodies.
    Proudfoot JM; Beilin LJ; Croft KD
    Biochem Biophys Res Commun; 1995 Jan; 206(2):455-61. PubMed ID: 7826362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Single passive smoking exposure induces no measurable oxidation of low density lipoproteins].
    Oguogho A; Kritz H; Sinzinger H
    Wien Klin Wochenschr; 1996; 108(18):589-92. PubMed ID: 9012143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein.
    Gopaul NK; Nourooz-Zadeh J; Mallet AI; Anggård EE
    Biochem Biophys Res Commun; 1994 Apr; 200(1):338-43. PubMed ID: 8166702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the alpha,beta-unsaturated keto functionality of 2'-hydroxychalcones as a novel antioxidant pharmacophore.
    Stevens JF; Miranda CL; Frei B; Buhler DR
    Chem Res Toxicol; 2003 Oct; 16(10):1277-86. PubMed ID: 14565769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of low-density lipoprotein.
    Ferguson E; Singh RJ; Hogg N; Kalyanaraman B
    Arch Biochem Biophys; 1997 May; 341(2):287-94. PubMed ID: 9169017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide inhibits peroxynitrite-induced production of hydroxyeicosatetraenoic acids and F2-isoprostanes in phosphatidylcholine liposomes.
    Laskey RE; Mathews WR
    Arch Biochem Biophys; 1996 Jun; 330(1):193-8. PubMed ID: 8651696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of F2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein.
    Gopaul NK; Nourooz-Zadeh J; Mallet AI; Anggård EE
    FEBS Lett; 1994 Jul; 348(3):297-300. PubMed ID: 8034058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of caffeine on oxidation susceptibility of human plasma low density lipoproteins.
    Krisko A; Kveder M; Pifat G
    Clin Chim Acta; 2005 May; 355(1-2):47-53. PubMed ID: 15820477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of prostaglandin E1 on in vitro oxidation of human low density lipoproteins.
    Sinzinger H; Leitinger N; Oguogho A; Rogatti W
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():409-11. PubMed ID: 7732884
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of SIN-1 on the oxygenated metabolism of arachidonic acid in blood platelets and endothelial cells].
    Lagarde M; Croset M; Bordet JC
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):216-7. PubMed ID: 3550640
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of plasma very low density lipoprotein, low density lipoprotein and high density lipoprotein on platelet aggregation in endogenous hypertriglyceridemia].
    Deng Z; Liu B; Zhou J; Zhang Z; Liu Y; Bai H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):704-7. PubMed ID: 14619587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of peroxynitrite and nitric oxide with LDL.
    Botti H; Trostchansky A; Batthyány C; Rubbo H
    IUBMB Life; 2005 Jun; 57(6):407-12. PubMed ID: 16012049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of strenuous arm exercise on oxidized-LDL-potentiated platelet activation in individuals with spinal cord injury.
    Wang JS; Yang CF; Wong MK; Chow SE; Chen JK
    Thromb Haemost; 2000 Jul; 84(1):118-23. PubMed ID: 10928481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation.
    Santos CX; Anjos EI; Augusto O
    Arch Biochem Biophys; 1999 Dec; 372(2):285-94. PubMed ID: 10600166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.